Pfizer (PFE)
(Real Time Quote from BATS)
$28.60 USD
-0.09 (-0.31%)
Updated May 24, 2024 01:06 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 81 - 100 ( 560 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 7.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended April 7.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 31.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Biotechnology- Weekly Retail Sales Tracker for Solid Tumors - Week Ended March 24.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended March 17.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 10.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 31123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Neurology Prescription Sales Tracker - Week Ending 3/3/23
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 3.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 3123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 17.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended February 17.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 22123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended February 10.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D